Linkedin

News and events

  • All
  • Events
  • Press releases
  • Publications
All
  • All
  • Events
  • Press releases
  • Publications

ExeVir Bio Appoints a Chief Scientific Officer

Ghent, Belgium, 1 September 2023: ExeVir Bio, a biotech company
September 1, 2023
Read More

ExeVir Bio Awarded EUR 1.6m Grant for Dengue Research

Dengue is a mosquito borne viral infection listed by WHO
June 28, 2023
Read More

Bio International Convention – June 5-8, 2023 – Boston, USA

Our CEO and COO are attending this partnering event in
June 3, 2023
Read More

Antibody Engineering & Therapeutics Europe 2023 – June 6-8, 2023 – Amsterdam, The Netherlands

Our Head of Preclinical Development is attending this event in
June 3, 2023
Read More

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike

Currently circulating SARS-CoV-2 variants have gained complete or significant resistance
March 27, 2023
Read More